4.8 Article

Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies

期刊

CELL
卷 166, 期 6, 页码 1459-+

出版社

CELL PRESS
DOI: 10.1016/j.cell.2016.08.005

关键词

-

资金

  1. International AIDS Vaccine Initiative (IAVI) through the Neutralizing Antibody Consortium [SFP1849]
  2. National Institute of Allergy and Infectious Diseases (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery grant) [UM1AI100663, P01AI081625, R01AI073148]
  3. Ragon Institute of MGH, MIT, and Harvard
  4. Helen Hay Whitney Foundation
  5. IAVI
  6. United States Agency for International Development (USAID)
  7. Ministry of Foreign Affairs of the Netherlands
  8. Bill AMP
  9. Melinda Gates Foundation

向作者/读者索取更多资源

Induction of broadly neutralizing antibodies (bnAbs) is a primary goal of HIV vaccine development. VRC01-class bnAbs are important vaccine leads because their precursor B cells targeted by an engineered priming immunogen are relatively common among humans. This priming immunogen has demonstrated the ability to initiate a bnAb response in animal models, but recall and maturation toward bnAb development has not been shown. Here, we report the development of boosting immunogens designed to guide the genetic and functional maturation of previously primed VRC01-class precursors. Boosting a transgenic mouse model expressing germline VRC01 heavy chains produced broad neutralization of near-native isolates (N276A) and weak neutralization of fully native HIV. Functional and genetic characteristics indicate that the boosted mAbs are consistent with partially mature VRC01-class antibodies and place them on a maturation trajectory that leads toward mature VRC01-class bnAbs. The results show how reductionist sequential immunization can guide maturation of HIV bnAb responses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据